Compare TTI & QDEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TTI | QDEL |
|---|---|---|
| Founded | 1981 | 1979 |
| Country | United States | United States |
| Employees | N/A | 6500 |
| Industry | Oil & Gas Production | Medical Specialities |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.2B |
| IPO Year | 1996 | 2022 |
| Metric | TTI | QDEL |
|---|---|---|
| Price | $9.40 | $18.10 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 5 | 4 |
| Target Price | $10.40 | ★ $28.25 |
| AVG Volume (30 Days) | 1.5M | ★ 1.8M |
| Earning Date | 04-29-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 45.35 |
| EPS | ★ 0.06 | N/A |
| Revenue | N/A | ★ $2,730,200,000.00 |
| Revenue This Year | $4.70 | $3.51 |
| Revenue Next Year | $11.35 | $3.86 |
| P/E Ratio | $157.00 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $3.17 | $9.92 |
| 52 Week High | $12.54 | $35.58 |
| Indicator | TTI | QDEL |
|---|---|---|
| Relative Strength Index (RSI) | 41.91 | 65.20 |
| Support Level | $9.21 | $10.87 |
| Resistance Level | $10.86 | $19.76 |
| Average True Range (ATR) | 0.52 | 1.30 |
| MACD | -0.14 | 0.25 |
| Stochastic Oscillator | 19.11 | 79.50 |
Tetra Technologies Inc is a diversified oil and gas services company, focused on completion fluids and associated products and services, water management, frac flowback, production well testing, offshore rig cooling, and compression services. It has two reporting segments, namely Completion Fluids & Products and Water & Flowback Services. The Completion Fluids & Products Division manufactures and markets clear brine fluids, additives, and associated products and services. The Water & Flowback Services Segment provides onshore oil and gas operators with comprehensive water management services. The majority of revenue is from the Completion Fluids & Products segment.
QuidelOrtho Corp is engaged in the development, manufacturing, and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry, and transfusion medicine, which helps clinicians and patients to make decisions across the globe. Geographically, the company has its presence in North America, EMEA, China, and Other countries. It generates the majority of its revenue from North America.